Table 3.

Comparison of demographics and comorbidities.

Variables	Total (n = 1,575)	Trajectory 1 (n = 246)	Trajectory 2 (n = 464)	Trajectory 3 (n = 225)	Trajectory 4 (n = 435)	Trajectory 5 (n = 205)	p
Admission Age, Mean ± SD	62.37 ± 15.97	62.43 ± 15.75	62.80 ± 15.73	63.07 ± 16.77	61.76 ± 15.96	61.86 ± 15.95	0.806
Gender, n(%)							0.420
F	643 (40.83)	104 (42.28)	189 (40.73)	80 (35.56)	179 (41.15)	91 (44.39)
M	932 (59.17)	142 (57.72)	275 (59.27)	145 (64.44)	256 (58.85)	114 (55.61)
Congestive Heart Failure, n(%)							0.202
No	1,037 (65.84)	152 (61.79)	298 (64.22)	153 (68.00)	303 (69.66)	131 (63.90)
Yes	538 (34.16)	94 (38.21)	166 (35.78)	72 (32.00)	132 (30.34)	74 (36.10)
Cerebrovascular Disease, n(%)							0.195
No	1,340 (85.08)	198 (80.49)	395 (85.13)	194 (86.22)	372 (85.52)	181 (88.29)
Yes	235 (14.92)	48 (19.51)	69 (14.87)	31 (13.78)	63 (14.48)	24 (11.71)
Chronic Pulmonary Disease, n(%)							0.021
No	1,144 (72.63)	167 (67.89)	323 (69.61)	175 (77.78)	318 (73.10)	161 (78.54)
Yes	431 (27.37)	79 (32.11)	141 (30.39)	50 (22.22)	117 (26.90)	44 (21.46)
Diabetes, n(%)							0.325
No	1,075 (68.25)	164 (66.67)	313 (67.46)	167 (74.22)	290 (66.67)	141 (68.78)
Yes	500 (31.75)	82 (33.33)	151 (32.54)	58 (25.78)	145 (33.33)	64 (31.22)
Renal Disease, n(%)							0.582
No	1,194 (75.81)	180 (73.17)	346 (74.57)	178 (79.11)	333 (76.55)	157 (76.59)
Yes	381 (24.19)	66 (26.83)	118 (25.43)	47 (20.89)	102 (23.45)	48 (23.41)
Malignant Cancer, n(%)							0.050
No	1,409 (89.46)	230 (93.50)	416 (89.66)	205 (91.11)	383 (88.05)	175 (85.37)
Yes	166 (10.54)	16 (6.50)	48 (10.34)	20 (8.89)	52 (11.95)	30 (14.63)
Metastatic Solid Tumor, n(%)							0.333
No	1,518 (96.38)	241 (97.97)	443 (95.47)	220 (97.78)	418 (96.09)	196 (95.61)
Yes	57 (3.62)	5 (2.03)	21 (4.53)	5 (2.22)	17 (3.91)	9 (4.39)